HIV in Correctional Facilities: Role of Self-Report in Case Identification

Lyons, Thomas; Goldstein, Paul; Kiriazes, Jean
February 2006
AIDS Patient Care & STDs;Feb2006, Vol. 20 Issue 2, p93
Academic Journal
For treatment of HIV/AIDS in jails and prisons to be effective, these institutions must identify as many HIV-positive inmates as they can. We compare HIV status among a drug-addicted jail population determined through a physical examination and a voluntary HIV testing program, with self-reported status in an interview. Of 360 subjects interviewed and given physical examinations, approximately one third (110) took the voluntary HIV test and all were negative, and only 1 was identified as HIV-positive in the physical. However, 7 (2%) stated in the interview that they were HIV positive, none of whom took the HIV test. Five of the 7 also self-reported injection drug use and having shared needles. We conclude that inmate self-report is an important pathway for HIV case finding in correctional institutions.


Related Articles

  • Cerebral syphilitic gumma in HIV-infected patients: case report and review. Weinert, Letícia S.; Scheffel, Rafael S.; Zoratto, Gabriela; Samios, Vinícius; Jeffmann, Marcelo W.; Dora, José Miguel; Goldani, Luciano Z. // International Journal of STD & AIDS;Jan2008, Vol. 19 Issue 1, p62 

    Neurosyphilis presenting as a cerebral gumma is an uncommon event. To date there are seven cases of cerebral gumma reported in human immunodeficiency virus (HIV)-infected patients. We describe a HIV-infected patient with neurosyphilis presenting as an expanding central nervous system lesion and...

  • Scientifically Astute Activists Seek Common Ground With Clinicians on Testing New AIDS Drugs. Cotton, Paul // JAMA: Journal of the American Medical Association;8/8/90, Vol. 264 Issue 6, p666 

    Highlights the Sixth International Conference on AIDS in San Francisco, California wherein a tense truce between activists and scientists were made concerning the testing of AIDS drugs. Information on the parallel-track program whereby patients can use experimental drugs while trials are under...

  • Pragmatic Acts In HIV/AIDS Social Management Advertisements. Makinde, Toyin // Linguistik Online;2014, Vol. 66 Issue 5, p69 

    Studies on the social management of HIV and AIDS have focused on how awareness about HIV and AIDS has been created through organised and interpersonal communication. These studies have not investigated context-constrained language use in the advertisements on the disease despite the wide...

  • Exploring Lack of Trust in Care Providers and the Government as a Barrier to Health Service Use. Whetten, Kathryn; Whetten, Rachel; Leserman, Jane; Ostermann, Jan; Thielman, Nathan; Swartz, Marvin; Stangl, Dalene // American Journal of Public Health;Apr2006, Vol. 96 Issue 4, p716 

    Objectives. We examined associations between trust of health care providers and the government and health service use and outcomes. Methods. Interviews with a sample of 611 HIV-positive individuals included an attitudinal assessment measuring beliefs concerning the creation of AIDS, information...

  • GERMAN AIDS NUMBERS DROP. Wockner, Rex // Bay Windows;4/14/1999, pN.PAG 

    Presents information on the number of AIDS cases in Germany as of April 14, 1999. Decrease in the number of AIDS cases in 1998 compared in 1997; Total number of Germans that developed AIDS.

  • Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. Antinori, Andrea; Ammassari, Adriana; Giancola, Maria Letizia; Cingolani, Antonella; Grisetti, Susanna; Murri, Rita; Alba, Lucia; Ciancio, Bruno; Soldani, Fabio; Larussa, Dora; Ippolito, Giuseppe; De Luca, Andrea // Journal of NeuroVirology;Aug2001, Vol. 7 Issue 4, p323 

    Whereas most AIDS-related neurologic disorders have reduced incidence since HAART therapy was introduced, we find that the incidence of progressive multifocal leukoencephalopathy (PML) did not significantly differ between the preHAART and the HAART period (OR 0.78; 95% CI 0.41-1.50). These...

  • Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. Aksamit, A.J. // Journal of NeuroVirology;Aug2001, Vol. 7 Issue 4, p386 

    This open label study determined the outcome of non-AIDS progressive multifocal leukoencephalopathy patients treated with a standard dose of intravenous cytosine arabinoside. Nineteen patients with PML proven by brain biopsy or spinal fluid polymerase chain reaction were treated with intravenous...

  • Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: A monocenter observational study with clinical and JC virus load monitoring. Gasnault, Jacques; Kousignian, Pascale; Kahraman, Mufide; Rahoiljaon, Josoa; Matheron, Sophie; Delfraissy, Jean-François; Taoufik, Yassine // Journal of NeuroVirology;Aug2001, Vol. 7 Issue 4, p375 

    A monocenter observational study was conducted to determine the clinical and virological effects of cidofovir added to highly active anti-retroviral therapy (HAART) in AIDS-associated progressive multifocal leukoencephalopathy (PML). Exposure to other anti-viral drugs or late initiation of...

  • Control of the medical treatment of AIDS. Velichenko, V.; Pritykin, D. // Automation & Remote Control;Mar2006, Vol. 67 Issue 3, p493 

    This work deals with the statement and the solution of problems of optimal control of the human immune system affected by a human immunodeficiency virus (HIV). The solution is performed by the numerical methods of optimal control on the basis of a dynamic model of the development of an infection...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics